The Burrill Report
Download your complimentary copy of the January 2012 issue of The Burrill Report .
News
Biotech Dealmaking Gets off to a Strong Start in 2012 February 01, 2012 | Press Release
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
See all News
Portfolio Company News
2009 News Archive
Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical
Trial to Evaluate Safety of CCL2-LPM for Inflammatory Kidney Disease
April 16, 2009